Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
This piece breaks down the core influences on market indices, from macro indicators to liquidity, helping you anticipate possible moves.
27,686 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Investors grapple with AI-driven disruption as markets remain volatile in early 2026. Experts outline disciplined ste...
Dark Matter Technologies unveils a new feature that lets lenders deploy AI agents inside Empower LOS using the Model ...
Celsius Holdings delivered a blowout Q4 and full-year results, sending shares higher as revenue accelerates and margi...
Match Group's chief executive opened a direct message channel to employees, turning feedback into action and reshapin...
Credo Technology is set to report after the close, with investors watching margins and guidance as the stock prices i...
Uncover what historically cheap ultra-high-yield dividend opportunities look like, why prices swing, and how to build...
William Raveis Real Estate signs a strategic partnership with Lance Vermeulen Real Estate to expand Berkshire County ...
A wave of AI-driven efficiency moves is prompting banks to trim payrolls. The trend rekindles a widely circulated war...
HPE reports a landmark shift in its earnings mix, with networking revenue over half of profits amid the Juniper Netwo...
Investors are eyeing CAVA as a potential hit in fast casual. This article weighs growth prospects, unit economics, an...
SCHD will conduct its annual reconstitution on March 23, trimming energy exposure and leaning more on financials to d...